135 related articles for article (PubMed ID: 355182)
1. Double-blind comparison of bromperidol and perphenazine.
Woggon B; Angst J
Int Pharmacopsychiatry; 1978; 13(3):165-76. PubMed ID: 355182
[TBL] [Abstract][Full Text] [Related]
2. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
3. Results of a clinical trial with bromperidol C-C 2489/21.
Weiser G
Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
[TBL] [Abstract][Full Text] [Related]
4. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
5. [Results of a double blind study with bromperidol and perphenazine].
Woggon B
Int Pharmacopsychiatry; 1978; 13 Suppl 1():62-71. PubMed ID: 35481
[No Abstract] [Full Text] [Related]
6. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
[TBL] [Abstract][Full Text] [Related]
7. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Ahlfors UG; Dencker SJ; Gravem A; Remvig J
Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
[TBL] [Abstract][Full Text] [Related]
8. A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients.
Dencker SJ; Giös I; Mårtensson E; Nordén T; Nyberg G; Persson R; Roman G; Stockman O; Svärd KO
Psychopharmacology (Berl); 1994 Feb; 114(1):24-30. PubMed ID: 7846204
[TBL] [Abstract][Full Text] [Related]
9. Bromperidol maintenance in schizophrenia.
McEvoy JP; Wilson WH; Ban TA; Brannen JO; Berney S
Pharmacopsychiatria; 1982 May; 15(3):95-6. PubMed ID: 7100263
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients.
Brannen JO; McEvoy JP; Wilson WH; Petrie WM; Ban TA; Berney SA; Schaffer JD
Pharmacopsychiatria; 1981 Jul; 14(4):139-40. PubMed ID: 6116246
[No Abstract] [Full Text] [Related]
11. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
[TBL] [Abstract][Full Text] [Related]
12. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
Malfroid M; Hens L; Roosen P; Dom R
Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
[TBL] [Abstract][Full Text] [Related]
13. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.
Benfield P; Ward A; Clark BG; Jue SG
Drugs; 1988 Jun; 35(6):670-84. PubMed ID: 3048975
[TBL] [Abstract][Full Text] [Related]
14. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
[TBL] [Abstract][Full Text] [Related]
15. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Eufe R; Wegener G
Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
[No Abstract] [Full Text] [Related]
16. Preliminary note on the antipsychotic efficacy of bromperidol.
Bataille M
Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
[TBL] [Abstract][Full Text] [Related]
17. Clinical experiences in an open and a double-blind trial.
Pöldinger W
Acta Psychiatr Belg; 1978; 78(1):96-101. PubMed ID: 347884
[TBL] [Abstract][Full Text] [Related]
18. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy, extrapyramidal symptoms and serum levels: influence of administration schedules and concomitant drugs on serum bromperidol concentrations.
Fujii Y; Tateyama M; Kamisada M; Tanoue A; Takamiya M; Nakajima S; Itoh H
Folia Psychiatr Neurol Jpn; 1984; 38(2):121-36. PubMed ID: 6152433
[TBL] [Abstract][Full Text] [Related]
20. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
